UNH UnitedHealth Group Incorporated Common Stock (DE)
$397,54
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 10, 2026
52W-Spanne
$256–$462
69% of range
Analystenbewertung
BUY
34 analysts
Kursziel
$475
+20% upside
P/E (TTM)
30.1
ROE
12.0%
Nettogewinnmarge
2.7%
Über UnitedHealth Group Incorporated Common Stock (DE) Unternehmensübersicht von Wikipedia
UnitedHealth ist ein US-amerikanischer börsennotierter Versicherungskonzern mit Firmensitz in Minnetonka, Minnesota. Das Unternehmen ist im Aktienindex S&P 500 gelistet und wurde im Oktober 2012 anstelle von Kraft Foods in den Dow Jones Industrial Average Index aufgenommen. Mit einem Umsatz von 324,2 Mrd. US-Dollar, bei einem Gewinn von 28,4 Mrd. US-Dollar, steht UnitedHealth laut den Forbes Global 2000 auf Platz 15 der weltgrößten Unternehmen. Laut den Fortune 500 gehört es zu den fünf umsatzstärksten Unternehmen der Vereinigten Staaten. Das Unternehmen kam Mitte 2022 auf eine Marktkapitalisierung von 504 Mrd. USD.
Mehr lesen
UnitedHealth ist ein US-amerikanischer börsennotierter Versicherungskonzern mit Firmensitz in Minnetonka, Minnesota. Das Unternehmen ist im Aktienindex S&P 500 gelistet und wurde im Oktober 2012 anstelle von Kraft Foods in den Dow Jones Industrial Average Index aufgenommen. Mit einem Umsatz von 324,2 Mrd. US-Dollar, bei einem Gewinn von 28,4 Mrd. US-Dollar, steht UnitedHealth laut den Forbes Global 2000 auf Platz 15 der weltgrößten Unternehmen (Stand: Jahr 2023). Laut den Fortune 500 gehört es zu den fünf umsatzstärksten Unternehmen der Vereinigten Staaten (Stand: Jahr 2022). Das Unternehmen kam Mitte 2022 auf eine Marktkapitalisierung von 504 Mrd. USD.
UnitedHealth bietet Versicherungen verschiedener Art an; insbesondere im Bereich der Krankenversicherung in den Vereinigten Staaten ist das Unternehmen sehr stark tätig. Im Unternehmen sind rund 400.000 Mitarbeiter beschäftigt.
Geschichte
UnitedHealth wurde 1977 unter dem Firmennamen UnitedHealthCare Corporation gegründet. 1995 erwarb UnitedHealth das US-amerikanische Unternehmen The MetraHealth Companies. 2006 war das Unternehmen in einen Finanzskandal verwickelt, der zum Rücktritt von William W. McGuire führte. Im Februar 2022 kündigte UnitedHealth die Übernahme von Change Healthcare an, der größten Plattform für Gesundheitszahlungen in den USA, die das US-Justizministerium aus kartellrechtlichen Gründen zu blockieren versuchte; der Verkauf wurde jedoch im September vollzogen.
Im November 2023 wurde bekannt, dass der Konzern eine stark fehlerhafte Entscheidungssoftware genutzt hatte, um die Übernahme von Pflegekosten abzuwehren.
Am Morgen des 4. Dezember 2024 wurde der CEO der UnitedHealthcare Brian Thompson in Midtown Manhattan, New York City, vor dem Hotel New York Hilton Midtown, in dem UnitedHealth eine Investorentagung abhielt, erschossen.
Struktur
Die UnitedHealth Group hat zwei Tochtergesellschaften: Optum und UnitedHealthcare.
Optum
Optum wurde 2011 gegründet.
Es ist in drei Geschäftsbereiche unterteilt:
OptumHealth – bietet Primär- und Sekundärversorgung an.
OptumInsight – bietet Datenanalyse-, Technologie- und Betriebsdienstleistungen an.
OptumRX – bietet auch Apothekendienste an.
UnitedHealthcare
UnitedHealthcare ist ein Versicherungs- und Managed-Care-Unternehmen mit vier Hauptabteilungen:
UnitedHealthcare Employer and Individual – bietet Gesundheitsvorsorgepläne und Dienstleistungen für große nationale Arbeitgeber an.
UnitedHealthcare Medicare and Retirement – bietet Gesundheits- und Wellness-Dienstleistungen für Personen ab 65 Jahren an.
UnitedHealthcare Community and State – bedient staatliche Programme, die sich um wirtschaftlich Benachteiligte, medizinisch Unterversorgte und Menschen ohne arbeitgeberfinanzierten Gesundheitsschutz kümmern, im Austausch gegen eine monatliche Prämie pro Mitglied aus dem staatlichen Programm.
UnitedHealthcare Global – ist außerhalb der Vereinigten Staaten tätig
== Geschäftszahlen ==
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
UNH Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$397.54
Marktkapitalisierung
$360.97B
P/E (TTM)
30.1
EPS (TTM)
$13.23
Umsatz (TTM)
$447.57B
Dividendenrendite
2.2%
ROE
12.0%
Verschuldungsgrad
0.7
52W-Spanne
$256 – $462
UNH Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$447.57B
2021-12-31
→
2025-12-31
EPS
$13.23
2021-12-31
→
2025-12-31
Freier Cashflow
$16.07B
2021-12-31
→
2025-12-31
Margen
2.7%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
UNH
Peer-Median
P/E (TTM)
30.1
35.0
P/S (TTM) (K/V (TTM))
0.8
0.9
P/B (K/B)
3.6
3.5
EV / EBITDA
21.4
—
Price / FCF (Kurs / FCF)
22.5
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
UNH
Peer-Median
Operating Margin (Betriebsgewinnmarge)
4.2%
—
Net Profit Margin (Nettogewinnmarge)
2.7%
0.89%
ROA
4.0%
3.5%
ROE
12.0%
10.1%
ROIC
9.6%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
UNH
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.7
—
Current Ratio (Liquiditätsgrad)
0.8
1.6
Quick Ratio
0.4
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
UNH
Peer-Median
Revenue YoY (Umsatz YoY)
11.8%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
11.3%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
11.7%
—
EPS YoY (EPS VjV)
-14.7%
—
Net Income YoY (Nettogewinn YoY)
-16.3%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
UNH
Peer-Median
Payout Ratio (Ausschüttungsquote)
65.7%
—
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite
2.2%
Ausschüttungsquote
65.7%
5J Div CAGR
—
| Ex-Datum | Betrag |
|---|---|
| 15. Juni 2026 | $2,3200 |
| 9. März 2026 | $2,2100 |
| 8. Dezember 2025 | $2,2100 |
| 15. September 2025 | $2,2100 |
| 16. Juni 2025 | $2,2100 |
| 10. März 2025 | $2,1000 |
| 9. Dezember 2024 | $2,1000 |
| 16. September 2024 | $2,1000 |
| 17. Juni 2024 | $2,1000 |
| 8. März 2024 | $1,8800 |
| 1. Dezember 2023 | $1,8800 |
| 8. September 2023 | $1,8800 |
| 15. Juni 2023 | $1,8800 |
| 10. März 2023 | $1,6500 |
| 2. Dezember 2022 | $1,6500 |
| 9. September 2022 | $1,6500 |
| 16. Juni 2022 | $1,6500 |
| 11. März 2022 | $1,4500 |
| 3. Dezember 2021 | $1,4500 |
| 10. September 2021 | $1,4500 |
UNH Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
34 Analysten
- Starker Kauf 8 23,5%
- Kauf 19 55,9%
- Halten 7 20,6%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
26 Analysten · 2026-08-15
Median
$490.00
Jetzt
$397.54
Tief
$313.00
Hoch
$529.00
Median-Ziel
$490.00
+23,3%
Mittelwert-Ziel
$475.23
+19,5%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.25%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $6.38 | $4.95 | 1.4% |
| 31. März 2026 | $7.23 | $6.64 | 0.59% |
| 31. Dezember 2025 | $2.11 | $2.12 | -0.01% |
| 30. September 2025 | $2.92 | $2.82 | 0.10% |
| 30. Juni 2025 | $4.08 | $4.53 | -0.45% |
| 31. März 2025 | $7.20 | $7.36 | -0.16% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B | $257.14B | $242.16B | $226.25B | $201.16B | $184.84B | $157.11B | $130.47B | |
| Cost of Revenue | $50.66B | $46.69B | $38.77B | $33.70B | $31.03B | $30.75B | $28.12B | $27.00B | $24.11B | $24.42B | $16.21B | $3.83B | |
| SG&A Expense | $59.59B | $53.01B | $54.63B | $47.78B | $42.58B | $41.70B | $35.19B | $34.07B | $29.56B | $28.40B | $24.31B | $21.26B | |
| Operating Expenses | $428.60B | $367.99B | $339.26B | $295.73B | $263.63B | $234.74B | $222.47B | $208.90B | $185.95B | $171.91B | $146.09B | $120.20B | |
| Operating Income | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B | $19.68B | $17.34B | $15.21B | $12.93B | $11.02B | $10.27B | |
| Interest Expense | $4.00B | $3.91B | $3.25B | $2.09B | $1.66B | $1.66B | $1.70B | $1.40B | $1.19B | $1.07B | $790M | $618M | |
| Pretax Income | $14.70B | $20.07B | $29.11B | $26.34B | $22.31B | $20.74B | $17.98B | $15.94B | $14.02B | $11.86B | $10.23B | $9.66B | |
| Income Tax | $1.89B | $4.83B | $5.97B | $5.70B | $4.58B | $4.97B | $3.74B | $3.56B | $3.20B | $4.79B | $4.36B | $4.04B | |
| Net Income | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B | $10.56B | $7.02B | $5.81B | $5.62B | |
| EPS (Basic) | $13.28 | $15.64 | $24.12 | $21.47 | $18.33 | $16.23 | $14.55 | $12.45 | $10.95 | $7.37 | $6.10 | $5.78 | |
| EPS (Diluted) | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 | $16.03 | $14.33 | $12.19 | $10.72 | $7.25 | $6.01 | $5.70 | |
| Shares (Basic) | 908,000,000 | 921,000,000 | 928,000,000 | 937,000,000 | 943,000,000 | 949,000,000 | 951,000,000 | 963,000,000 | 964,000,000 | 952,000,000 | 953,000,000 | 972,000,000 | |
| Shares (Diluted) | 911,000,000 | 929,000,000 | 938,000,000 | 950,000,000 | 956,000,000 | 961,000,000 | 966,000,000 | 983,000,000 | 985,000,000 | 968,000,000 | 967,000,000 | 986,000,000 | |
| EBITDA | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B | $19.68B | $17.34B | $15.21B | $12.93B | $11.02B | $10.27B |
Bilanz 26
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24.36B | $25.31B | $25.43B | $23.36B | $21.38B | $16.92B | $10.98B | $10.87B | $11.98B | $10.43B | $10.92B | $7.50B | |
| Short-term Investments | $3.76B | $3.80B | $4.20B | $4.55B | $2.53B | $2.86B | $3.26B | $3.46B | $3.51B | $2.85B | $1.99B | $1.74B | |
| Receivables | $23.02B | $22.36B | $21.28B | $17.68B | $14.22B | $12.87B | $11.82B | $11.39B | $9.57B | $8.15B | $6.52B | $4.25B | |
| Inventory | $3.30B | $3.80B | $2.80B | $3.50B | $2.90B | · | · | · | · | · | · | · | |
| Prepaid Expense | $9.75B | $8.21B | $6.08B | $6.62B | $5.32B | $4.46B | $3.85B | $3.09B | $2.66B | $1.85B | $2.41B | $1.05B | |
| Current Assets | $90.58B | $85.78B | $78.44B | $69.07B | $61.76B | $53.72B | $42.63B | $38.69B | $37.08B | $33.88B | $31.64B | $23.56B | |
| PP&E (Net) | $10.76B | $10.55B | $11.45B | $10.13B | $8.97B | $8.63B | $8.70B | $8.46B | $7.01B | $5.90B | $4.86B | $4.42B | |
| Accum. Depreciation | $7.55B | $6.97B | $7.04B | $6.93B | $5.99B | $5.23B | $5.00B | $4.14B | $3.69B | $3.75B | $3.17B | $2.95B | |
| Goodwill | $110.50B | $106.73B | $103.73B | $93.35B | $75.80B | $71.34B | $65.66B | $58.91B | $54.56B | $47.58B | $44.45B | $32.94B | |
| Intangibles | $20.47B | $23.27B | $15.19B | $14.40B | $10.04B | $10.86B | $10.35B | $9.32B | $8.49B | $8.54B | $8.39B | $3.67B | |
| Other Non-current Assets | $23.01B | $19.59B | $17.30B | $15.03B | $12.53B | $11.51B | $9.33B | $4.33B | $3.58B | $3.04B | $3.12B | $2.97B | |
| Total Assets | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B | $152.22B | $139.06B | $122.81B | $111.25B | $86.30B | |
| Accounts Payable | $38.03B | $34.34B | $31.96B | $27.71B | $24.64B | $22.50B | $19.00B | $16.70B | $15.18B | $13.36B | $11.99B | $9.25B | |
| Current Liabilities | $114.90B | $103.77B | $99.05B | $89.24B | $78.29B | $72.42B | $61.78B | $53.21B | $50.46B | $49.25B | $42.90B | $30.62B | |
| Deferred Tax | $2.42B | $3.62B | $3.02B | $2.77B | $3.27B | $3.37B | $2.99B | $2.47B | $2.18B | $2.76B | $3.59B | $2.06B | |
| Other Non-current Liabilities | $18.25B | $15.94B | $14.46B | $12.84B | $11.79B | $12.31B | $10.14B | $5.73B | $5.56B | $4.83B | $1.48B | $1.36B | |
| Total Liabilities | $207.88B | $195.69B | $174.80B | $159.36B | $135.73B | $126.75B | $111.73B | $95.99B | $87.04B | $82.62B | $75.79B | $52.54B | |
| Long-term Debt | · | · | · | · | $46.00B | $43.47B | $40.68B | $36.55B | $31.69B | $32.97B | $31.96B | $17.41B | |
| Total Debt | $72.32B | $72.36B | $58.26B | $54.51B | $46.00B | $43.47B | $40.68B | $36.55B | $31.69B | $32.97B | $32.09B | $17.41B | |
| Common Stock | $9M | $9M | $9M | $9M | $10M | $10M | $9M | $10M | $10M | $10M | $10M | $10M | |
| Paid-in Capital | $559M | $0 | $0 | · | $0 | $0 | $7M | $0 | $1.70B | $0 | $29M | $0 | |
| Retained Earnings | $95.60B | $96.04B | $95.77B | $86.16B | $77.13B | $69.30B | $61.18B | $55.85B | $48.73B | $40.95B | $37.12B | $33.84B | |
| AOCI | $-2.06B | $-3.39B | $-7.03B | $-8.39B | $-5.38B | $-3.81B | $-3.58B | $-4.16B | $-2.67B | $-2.68B | $-3.33B | $-1.39B | |
| Stockholders' Equity | $100.09B | $98.27B | $94.42B | $81.45B | $75.05B | $68.33B | $60.44B | $54.32B | $49.83B | $38.18B | $33.73B | $32.45B | |
| Liabilities + Equity | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B | $152.22B | $139.06B | $122.81B | $111.25B | $86.38B | |
| Shares Outstanding | 906,000,000 | 915,000,000 | 924,000,000 | 934,000,000 | 941,000,000 | 946,000,000 | 948,000,000 | 960,000,000 | 969,000,000 | 952,000,000 | 953,000,000 | 954,000,000 |
Cashflow 18
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4.36B | $4.10B | $3.97B | $3.40B | $3.10B | $2.89B | $2.72B | $2.43B | $2.25B | $2.06B | $1.69B | $1.48B | |
| Stock-based Comp | $971M | $1.02B | $1.06B | $925M | $800M | $679M | $697M | $638M | $597M | $485M | $406M | $364M | |
| Deferred Tax | $-1.75B | $-296M | $-245M | $-673M | $130M | $-8M | $230M | $42M | $-965M | $81M | $-73M | $-117M | |
| Amort. of Intangibles | $1.70B | $1.70B | $1.60B | $1.30B | $1.20B | $1.10B | $1.00B | $898M | $896M | $882M | $650M | $524M | |
| Operating Cash Flow | $19.70B | $24.20B | $29.07B | $26.21B | $22.34B | $22.17B | $18.46B | $15.71B | $13.60B | $9.79B | $9.74B | $8.05B | |
| CapEx | $3.62B | $3.50B | $3.39B | $2.80B | $2.45B | $2.05B | $2.07B | $2.06B | $2.02B | $1.71B | $1.56B | $1.52B | |
| Investing Cash Flow | $-8.69B | $-20.53B | $-15.57B | $-28.48B | $-10.37B | $-12.53B | $-12.70B | $-12.38B | $-8.60B | $-9.36B | $-18.39B | $-2.53B | |
| Debt Issued | $2.97B | $17.81B | $6.39B | $14.82B | $6.93B | $4.86B | $5.44B | $6.93B | $5.29B | $3.97B | $11.98B | $2.00B | |
| Net Debt Issued | $-81M | $14.81B | $4.27B | $11.80B | $3.78B | $1.71B | $3.69B | $4.33B | $893M | $1.37B | $10.94B | $1.19B | |
| Stock Issued | $827M | $1.85B | $1.35B | $1.25B | $1.35B | $1.44B | $1.04B | $838M | $688M | $429M | $402M | $462M | |
| Stock Repurchased | $5.54B | $9.00B | $8.00B | $7.00B | $5.00B | $4.25B | $5.50B | $4.50B | $1.50B | $1.28B | $1.20B | $4.01B | |
| Net Stock Activity | $-4.72B | $-7.15B | $-6.65B | $-5.75B | $-3.65B | $-2.81B | $-4.46B | $-3.66B | $-812M | $-851M | $-798M | $-3.55B | |
| Dividends Paid | $7.92B | $7.53B | $6.76B | $5.99B | $5.28B | $4.58B | $3.93B | $3.32B | $2.77B | $2.26B | $1.79B | $1.36B | |
| Financing Cash Flow | $-11.64B | $-3.51B | $-11.53B | $4.23B | $-7.46B | $-3.59B | $-5.62B | $-4.37B | $-3.44B | $-1.01B | $12.24B | $-5.29B | |
| Net Change in Cash | $-947M | $-115M | $2.06B | $1.99B | $4.45B | $5.94B | $119M | $-1.11B | $1.55B | $-493M | $3.43B | $219M | |
| Taxes Paid | $3.71B | $4.62B | $6.08B | $5.22B | $3.97B | $4.93B | $3.54B | $3.26B | $4.00B | $4.73B | $4.40B | $4.02B | |
| Free Cash Flow | $16.07B | $20.70B | $25.68B | $23.40B | $19.89B | $20.12B | $16.39B | $13.65B | $11.57B | $8.09B | $8.18B | $6.53B | |
| Levered FCF | $12.59B | $17.74B | $23.10B | $21.76B | $18.57B | $18.86B | $15.04B | $12.56B | $10.66B | $7.45B | $7.73B | $6.17B |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 4.2% | 8.1% | 8.7% | 8.8% | 8.3% | 8.7% | 8.1% | 7.7% | 7.6% | 7.0% | 7.0% | 7.9% | |
| Net Margin | 2.7% | 3.6% | 6.0% | 6.2% | 6.0% | 6.0% | 5.7% | 5.3% | 5.2% | 3.8% | 3.7% | 4.3% | |
| Pretax Margin | 3.3% | 5.0% | 7.8% | 8.1% | 7.8% | 8.1% | 7.4% | 7.0% | 7.0% | 6.4% | 6.5% | 7.4% | |
| EBITDA Margin | 4.2% | 8.1% | 8.7% | 8.8% | 8.3% | 8.7% | 8.1% | 7.7% | 7.6% | 7.0% | 7.0% | 7.9% | |
| ROA | 4.0% | 4.8% | 8.6% | 8.8% | 8.4% | 8.3% | 8.5% | 8.2% | 8.1% | 6.0% | 5.9% | 6.7% | |
| ROE | 12.0% | 14.5% | 24.3% | 25.2% | 23.3% | 22.6% | 23.4% | 22.4% | 21.7% | 18.5% | 17.4% | 17.3% | |
| ROIC | 9.6% | 14.4% | 16.9% | 16.4% | 15.7% | 15.2% | 15.4% | 14.8% | 14.4% | 10.8% | 9.6% | 12.0% |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | |
| Quick Ratio | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.4 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.6 | 0.9 | 1.0 | 0.5 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.8 | 0.5 | |
| Interest Coverage | 4.7 | 8.3 | 10.0 | 13.6 | 14.4 | 13.5 | 11.6 | 12.4 | 12.8 | 12.1 | 14.0 | 16.6 |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.5 | 1.3 | 1.4 | 1.4 | 1.4 | 1.4 | 1.5 | 1.6 | 1.5 | 1.6 | 1.6 | 1.6 | |
| Inventory Turnover | 14.3 | 14.1 | 12.3 | 10.5 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 19.7 | 18.3 | 19.1 | 20.3 | 21.2 | 20.8 | 20.9 | 21.6 | 22.7 | 25.2 | 29.2 | 35.7 |
Wachstumsraten 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 7.7% | 14.6% | 12.7% | 11.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.3% | 11.7% | 13.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.7% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -14.7% | -35.0% | 12.7% | 17.2% | 12.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -14.5% | -5.0% | 14.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -16.3% | -35.6% | 11.2% | 16.4% | 12.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -15.7% | -5.9% | 13.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -4.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 11.6% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B | $257.14B | $242.16B | $226.25B | $201.16B | $184.84B | $157.11B | $130.47B | |
| Net Income TTM | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B | $10.56B | $7.02B | $5.81B | $5.62B | |
| Market Cap | $299.08B | $462.86B | $486.46B | $495.19B | $472.51B | $331.74B | $278.69B | $239.16B | $213.63B | $152.36B | $112.11B | $96.44B | |
| Enterprise Value | $343.28B | $506.11B | $515.09B | $521.79B | $494.61B | $355.43B | $305.13B | $261.39B | $229.83B | $172.05B | $131.29B | $104.61B | |
| P/E | 25.0 | 32.6 | 22.1 | 25.0 | 27.8 | 21.9 | 20.5 | 20.4 | 20.6 | 22.1 | 19.6 | 17.7 | |
| P/S | 0.7 | 1.2 | 1.3 | 1.5 | 1.6 | 1.3 | 1.2 | 1.1 | 1.1 | 0.8 | 0.7 | 0.7 | |
| P/B | 3.0 | 4.7 | 5.2 | 6.1 | 6.3 | 4.9 | 4.6 | 4.4 | 4.3 | 4.0 | 3.3 | 3.0 | |
| P / Cash Flow | 15.2 | 19.1 | 16.7 | 18.9 | 21.1 | 15.0 | 15.1 | 15.2 | 15.7 | 15.6 | 11.5 | 12.0 | |
| P / FCF | 18.6 | 22.4 | 18.9 | 21.2 | 23.8 | 16.5 | 17.0 | 17.5 | 18.5 | 18.8 | 13.7 | 14.8 | |
| EV / EBITDA | 18.1 | 15.7 | 15.9 | 18.4 | 20.6 | 15.9 | 15.5 | 15.1 | 15.1 | 13.3 | 11.9 | 10.2 | |
| EV / FCF | 21.4 | 24.4 | 20.1 | 22.3 | 24.9 | 17.7 | 18.6 | 19.1 | 19.9 | 21.3 | 16.0 | 16.0 | |
| EV / Revenue | 0.8 | 1.3 | 1.4 | 1.6 | 1.7 | 1.4 | 1.3 | 1.2 | 1.1 | 0.9 | 0.8 | 0.8 | |
| Dividend Yield | 2.6% | 1.6% | 1.4% | 1.2% | 1.1% | 1.4% | 1.4% | 1.4% | 1.3% | 1.5% | 1.6% | 1.4% | |
| Earnings Yield | 4.0% | 3.1% | 4.5% | 4.0% | 3.6% | 4.6% | 4.9% | 4.9% | 4.9% | 4.5% | 5.1% | 5.6% | |
| Payout Ratio | 65.7% | 52.3% | 30.2% | 29.8% | 30.6% | 29.8% | 28.4% | 27.7% | 26.3% | 32.2% | 30.7% | 24.2% | |
| Annual Payout | $7.92B | $7.53B | $6.76B | $5.99B | $5.28B | $4.58B | $3.93B | $3.32B | $2.77B | $2.26B | $1.79B | $1.36B |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $112.03B | $111.72B | $113.22B | $113.16B | $111.62B | $109.58B | $100.81B | $100.82B | $98.86B | $99.80B | $94.43B | $92.36B | $92.90B | $91.93B | $82.79B | $80.89B | |
| Cost of Revenue | $13.38B | $12.82B | $12.68B | $12.57B | $13.02B | $12.39B | $12.46B | $11.83B | $11.34B | $11.06B | $10.19B | $9.42B | $9.75B | $9.40B | $8.31B | $8.31B | |
| SG&A Expense | $14.27B | $15.39B | $17.00B | $15.22B | $13.78B | $13.59B | $12.49B | $13.28B | $13.16B | $14.08B | $13.34B | $13.86B | $13.81B | $13.62B | $13.01B | $11.66B | |
| Operating Expenses | $104.04B | $102.73B | $112.83B | $108.85B | $106.47B | $100.46B | $93.03B | $92.11B | $90.98B | $91.86B | $86.74B | $83.83B | $84.85B | $83.84B | $75.90B | $73.43B | |
| Operating Income | $7.99B | $8.99B | $380M | $4.32B | $5.15B | $9.12B | $7.77B | $8.71B | $7.88B | $7.93B | $7.69B | $8.53B | $8.06B | $8.09B | $6.89B | $7.46B | |
| Interest Expense | $962M | $955M | $974M | $1.00B | $1.03B | $998M | $1.00B | $1.07B | $985M | $844M | $830M | $834M | $828M | $754M | $676M | $516M | |
| Pretax Income | $6.97B | $7.96B | $-720M | $3.23B | $4.08B | $8.11B | $6.79B | $7.61B | $5.67B | $1M | $6.86B | $7.69B | $7.23B | $7.33B | $6.21B | $6.95B | |
| Income Tax | $1.30B | $1.48B | $-938M | $686M | $510M | $1.63B | $1.01B | $1.36B | $1.24B | $1.22B | $1.18B | $1.65B | $1.57B | $1.56B | $1.31B | $1.56B | |
| Net Income | $5.48B | $6.28B | $10M | $2.35B | $3.41B | $6.29B | $5.54B | $6.05B | $4.22B | $-1.41B | $5.46B | $5.84B | $5.47B | $5.61B | $4.76B | $5.26B | |
| EPS (Basic) | $6.06 | $6.92 | $0.03 | $2.59 | $3.76 | $6.90 | $6.03 | $6.56 | $4.58 | $-1.53 | $5.91 | $6.31 | $5.89 | $6.01 | $5.09 | $5.63 | |
| EPS (Diluted) | $6.04 | $6.90 | $0.05 | $2.59 | $3.74 | $6.85 | $5.99 | $6.51 | $4.54 | $-1.53 | $5.85 | $6.24 | $5.82 | $5.95 | $5.02 | $5.55 | |
| Shares (Basic) | 902,000,000 | 908,000,000 | -1,817,000,000 | 906,000,000 | 907,000,000 | 912,000,000 | -1,845,000,000 | 923,000,000 | 921,000,000 | 922,000,000 | -1,861,000,000 | 926,000,000 | 930,000,000 | 933,000,000 | -1,876,000,000 | 935,000,000 | |
| Shares (Diluted) | 906,000,000 | 910,000,000 | -1,825,000,000 | 908,000,000 | 910,000,000 | 918,000,000 | -1,851,000,000 | 930,000,000 | 928,000,000 | 922,000,000 | -1,881,000,000 | 936,000,000 | 940,000,000 | 943,000,000 | -1,902,000,000 | 948,000,000 | |
| EBITDA | $7.99B | $8.99B | · | $4.32B | $5.15B | $9.12B | · | $8.71B | $7.88B | $7.93B | · | $8.53B | $8.06B | $8.09B | · | $7.46B |
Bilanz 26
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $28.59B | $28.00B | $24.36B | $27.21B | $28.60B | $30.72B | $25.31B | $32.40B | $26.29B | $28.41B | · | $38.91B | $41.81B | $41.91B | · | $38.84B | |
| Short-term Investments | $2.88B | $3.23B | $3.76B | $3.40B | $3.42B | $3.57B | $3.80B | $4.73B | $5.04B | $4.30B | · | $5.18B | $4.47B | $4.58B | · | $3.68B | |
| Receivables | $21.57B | $26.59B | $23.02B | $22.67B | $24.14B | $26.94B | $22.36B | $20.02B | $23.11B | $27.20B | · | $20.67B | $17.95B | $22.41B | · | $17.05B | |
| Inventory | · | · | $3.30B | · | · | · | $3.80B | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $9.10B | $8.72B | $9.75B | $9.02B | $8.96B | $9.04B | $8.21B | $7.64B | $7.42B | $6.13B | · | $5.77B | $5.88B | $6.45B | · | $5.66B | |
| Current Assets | $86.86B | $91.13B | $90.58B | $95.07B | $93.70B | $96.28B | $85.78B | $92.26B | $92.04B | $88.94B | · | $91.91B | $89.87B | $93.89B | · | $82.94B | |
| PP&E (Net) | $10.76B | $10.67B | $10.76B | $11.10B | $10.92B | $10.73B | $10.55B | $10.14B | $9.80B | $10.43B | · | $11.07B | $10.93B | $10.64B | · | $9.47B | |
| Accum. Depreciation | · | · | $7.55B | · | · | · | $6.97B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $110.64B | $110.51B | $110.50B | $110.34B | $107.68B | $107.57B | $106.73B | $105.98B | $105.44B | $105.66B | $103.73B | $101.70B | $101.67B | $100.41B | $93.35B | $83.90B | |
| Intangibles | $19.75B | $20.09B | $20.47B | $22.79B | $22.51B | $22.95B | $23.27B | $23.59B | $14.73B | $15.54B | · | $15.20B | $15.64B | $16.16B | · | $10.79B | |
| Other Non-current Assets | $24.00B | $23.46B | $23.01B | $22.98B | $21.30B | $20.39B | $19.59B | $18.65B | $17.94B | $17.70B | · | $16.71B | $16.07B | $15.69B | · | $14.41B | |
| Total Assets | $309.73B | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | $298.28B | $299.31B | $286.06B | $284.21B | $273.72B | $282.06B | $280.16B | $283.68B | $245.71B | $243.06B | |
| Accounts Payable | $39.74B | $38.63B | $38.03B | $36.03B | $34.33B | $33.57B | $34.34B | $33.08B | $30.89B | $30.74B | · | $31.16B | $29.52B | $29.86B | · | $27.23B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | $7.30B | · | $2.60B | $4.40B | $8.20B | · | · | |
| Current Liabilities | $111.82B | $114.12B | $114.90B | $115.53B | $110.78B | $113.47B | $103.77B | $101.56B | $104.67B | $104.43B | · | $114.18B | $112.98B | $116.48B | · | $100.94B | |
| Deferred Tax | $2.72B | $2.86B | $2.42B | $3.16B | $3.80B | $3.90B | $3.62B | $4.01B | $3.63B | $4.17B | · | $2.21B | $2.50B | $2.83B | · | $1.66B | |
| Other Non-current Liabilities | $19.73B | $18.90B | $18.25B | $18.37B | $15.71B | $15.96B | $15.94B | $15.17B | $14.79B | $14.84B | · | $13.62B | $13.26B | $13.08B | · | $12.11B | |
| Total Liabilities | $203.78B | $207.32B | $207.88B | $209.46B | $203.79B | $204.62B | $195.69B | $194.85B | $186.82B | $187.29B | · | $188.08B | $188.01B | $193.06B | · | $160.14B | |
| Total Debt | $69.50B | $71.44B | · | $72.40B | $73.50B | $71.28B | · | $74.10B | $63.73B | $71.15B | · | $60.68B | $63.67B | $68.86B | · | $45.44B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $10M | |
| Paid-in Capital | $0 | $556M | $559M | $394M | · | · | $0 | $461M | $373M | · | · | · | · | · | · | · | |
| Retained Earnings | $100.96B | $99.88B | $95.60B | $97.59B | $97.25B | $97.93B | $96.04B | $96.52B | $92.40B | $90.12B | · | $93.17B | $89.99B | $88.85B | · | $83.72B | |
| AOCI | $-2.52B | $-2.56B | $-2.06B | $-2.21B | $-2.54B | $-2.90B | $-3.39B | $-2.45B | $-3.42B | $-3.44B | · | $-8.69B | $-7.65B | $-7.55B | · | $-9.09B | |
| Stockholders' Equity | $104.51B | $103.89B | $100.09B | $101.57B | $100.47B | $100.81B | $98.27B | $99.88B | $94.68B | $92.37B | $94.42B | $89.56B | $87.37B | $85.82B | $81.45B | $78.06B | |
| Liabilities + Equity | $309.73B | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | $298.28B | $299.31B | $286.06B | $284.21B | · | $282.06B | $280.16B | $283.68B | · | $243.06B | |
| Shares Outstanding | 905,000,000 | 908,000,000 | 906,000,000 | 906,000,000 | 905,000,000 | 910,000,000 | 915,000,000 | 923,000,000 | 921,000,000 | 920,000,000 | 924,000,000 | 925,000,000 | 927,000,000 | 932,000,000 | 934,000,000 | 935,000,000 |
Cashflow 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.04B | $1.03B | $1.12B | $1.10B | $1.08B | $1.06B | $1.04B | $1.04B | $1.02B | $997M | $974M | $1.01B | $1.02B | $970M | $982M | $828M | |
| Stock-based Comp | $276M | $348M | $176M | $223M | $197M | $375M | $187M | $237M | $222M | $372M | $208M | $247M | $242M | $362M | $250M | $171M | |
| Deferred Tax | $-129M | $540M | $-733M | $-932M | $-151M | $64M | $-62M | $124M | $-331M | $-27M | $249M | $-12M | $-150M | $-332M | $-83M | $-575M | |
| Operating Cash Flow | $11.05B | $8.91B | $1.11B | $5.95B | $7.19B | $5.46B | $2.37B | $13.95B | $6.75B | $1.14B | $-5.19B | $6.90B | $11.03B | $16.33B | $-4.53B | $18.55B | |
| CapEx | $799M | $763M | $948M | $890M | $886M | $898M | $912M | $991M | $853M | $743M | $959M | $838M | $829M | $760M | $866M | $724M | |
| Investing Cash Flow | $-1.80B | $-2.45B | $-2.61B | $-4.56B | $-1.44B | $-74M | $-1.12B | $-5.65B | $-7.42B | $-6.34B | $-1.19B | $-2.64B | $-728M | $-11.02B | $-15.37B | $-847M | |
| Debt Issued | · | · | $0 | $0 | $2.97B | $0 | $0 | $11.89B | $0 | $5.92B | $0 | $0 | $-7M | $6.40B | $8.90B | $0 | |
| Net Debt Issued | · | $-1.50B | · | · | · | $0 | · | · | · | $5.17B | · | · | · | $5.03B | · | · | |
| Stock Issued | $128M | $231M | $24M | $222M | $221M | $360M | $235M | $867M | $258M | $486M | $314M | $411M | $284M | $344M | $169M | $328M | |
| Stock Repurchased | $1.65B | $0 | $0 | $0 | $2.54B | $3.00B | $4.97B | $956M | $0 | $3.07B | $1.50B | $1.50B | $3.00B | $2.00B | $1.00B | $1.00B | |
| Net Stock Activity | · | $231M | · | · | · | $-2.64B | · | · | · | $-2.59B | · | · | · | $-1.66B | · | · | |
| Dividends Paid | $2.09B | $2.00B | $2.00B | $2.00B | $2.00B | $1.91B | $1.93B | $1.94B | $1.94B | $1.73B | $1.74B | $1.74B | $1.75B | $1.54B | $1.54B | $1.54B | |
| Financing Cash Flow | $-8.62B | $-2.99B | $-1.03B | $-2.77B | $-7.95B | $99M | $-8.34B | $-2.21B | $-1.20B | $8.23B | $-7.16B | $-7.10B | $-10.46B | $13.19B | $4.39B | $-3.42B | |
| Net Change in Cash | $584M | $3.64B | $-2.85B | $-1.39B | $-2.12B | $5.41B | $-7.09B | $6.11B | $-2.13B | $2.99B | $-13.49B | $-2.90B | $-100M | $18.55B | $-15.48B | $14.23B | |
| Free Cash Flow | · | $8.15B | · | · | · | $4.56B | · | · | · | $401M | · | · | · | $15.57B | · | · | |
| Levered FCF | · | $7.37B | · | · | · | $3.76B | · | · | · | $1.03T | · | · | · | $14.97B | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 7.1% | 8.1% | · | 3.8% | 4.6% | 8.3% | · | 8.6% | 8.0% | 8.0% | · | 9.2% | 8.7% | 8.8% | · | 9.2% | |
| Net Margin | 4.9% | 5.6% | · | 2.1% | 3.0% | 5.7% | · | 6.0% | 4.3% | -1.4% | · | 6.3% | 5.9% | 6.1% | · | 6.5% | |
| Pretax Margin | 6.2% | 7.1% | · | 2.9% | 3.7% | 7.4% | · | 7.5% | 5.7% | 0.00% | · | 8.3% | 7.8% | 8.0% | · | 8.6% | |
| EBITDA Margin | 7.1% | 8.1% | · | 3.8% | 4.6% | 8.3% | · | 8.6% | 8.0% | 8.0% | · | 9.2% | 8.7% | 8.8% | · | 9.2% | |
| ROA | 1.8% | 2.0% | · | 0.76% | 1.1% | 2.1% | · | 2.1% | 1.5% | -0.50% | · | 2.2% | 2.1% | 2.2% | · | 2.3% | |
| ROE | 5.3% | 6.1% | · | 2.3% | 3.5% | 6.5% | · | 6.4% | 4.6% | -1.6% | · | 7.0% | 6.7% | 6.9% | · | 7.0% | |
| ROIC | 3.7% | 4.2% | · | 1.9% | 2.6% | 4.2% | · | 4.1% | 3.9% | -5922.1% | · | 4.5% | 4.2% | 4.1% | · | 4.7% |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| Quick Ratio | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | |
| LT Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | |
| Interest Coverage | 8.3 | 9.4 | · | 4.3 | 5.0 | 9.1 | · | 8.1 | 8.0 | 9.4 | · | 10.2 | 9.7 | 10.7 | · | 14.5 |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 4.9 | 4.2 | · | 5.3 | 4.7 | 4.0 | · | 5.0 | 4.8 | 4.0 | · | 4.9 | 5.1 | 4.5 | · | 5.2 |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $448.53B | $446.07B | · | $435.17B | $420.87B | $409.05B | · | $391.83B | $383.92B | $376.99B | · | $358.09B | $346.06B | $333.31B | · | $313.71B | |
| Net Income TTM | $17.52B | $18.33B | · | $18.10B | $19.97B | $15.15B | · | $14.70B | $14.12B | $15.52B | · | $22.19B | $21.42B | $20.97B | · | $19.45B | |
| Market Cap | $376.15B | $245.70B | · | $312.84B | $282.33B | $476.61B | · | $539.66B | $469.03B | $455.12B | · | $466.38B | $445.55B | $440.45B | · | $472.21B | |
| Enterprise Value | $414.18B | $285.91B | · | $354.63B | $323.81B | $513.61B | · | $576.63B | $501.43B | $493.56B | · | $482.96B | $462.94B | $462.81B | · | $475.12B | |
| P/E | 21.6 | 13.5 | · | 17.5 | 14.4 | 32.0 | · | 37.1 | 33.8 | 30.0 | · | 21.4 | 21.2 | 21.4 | · | 24.7 | |
| P/S | 0.8 | 0.6 | · | 0.7 | 0.7 | 1.2 | · | 1.4 | 1.2 | 1.2 | · | 1.3 | 1.3 | 1.3 | · | 1.5 | |
| P/B | 3.6 | 2.4 | · | 3.1 | 2.8 | 4.7 | · | 5.4 | 5.0 | 4.9 | · | 5.2 | 5.1 | 5.1 | · | 6.0 | |
| P / Cash Flow | · | 27.6 | · | · | · | 87.4 | · | · | · | 397.8 | · | · | · | 27.0 | · | · | |
| P / FCF | · | 30.2 | · | · | · | 104.6 | · | · | · | 1135.0 | · | · | · | 28.3 | · | · | |
| EV / EBITDA | 51.8 | 31.8 | · | 82.2 | 62.9 | 56.3 | · | 66.2 | 63.7 | 62.2 | · | 56.6 | 57.5 | 57.2 | · | 63.7 | |
| EV / FCF | · | 35.1 | · | · | · | 112.7 | · | · | · | 1230.8 | · | · | · | 29.7 | · | · | |
| EV / Revenue | 0.9 | 0.6 | · | 0.8 | 0.8 | 1.3 | · | 1.5 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.4 | · | 1.5 | |
| Earnings Yield | 4.6% | 7.4% | · | 5.7% | 6.9% | 3.1% | · | 2.7% | 3.0% | 3.3% | · | 4.7% | 4.7% | 4.7% | · | 4.0% | |
| Payout Ratio | · | 31.9% | · | · | · | 30.4% | · | · | · | -122.7% | · | · | · | 27.4% | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| Umsatz | $447.57B | — | — | $400.28B | — |
| Betriebsgewinnmarge % | 4.2% | — | — | 8.1% | — |
| Nettoergebnis | $12.06B | — | — | $14.40B | — |
| Verwässerte EPS | $13.23 | — | — | $15.51 | — |
Bilanz
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.7 | — | — | 0.7 | — |
| Liquiditätsgrad | 0.8 | — | — | 0.8 | — |
| Quick Ratio | 0.4 | — | — | 0.5 | — |
Cashflow
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| Freier Cashflow | $16.07B | — | — | $20.70B | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
- Ist die Aktie von UnitedHealth noch unterbewertet?
- UnitedHealth Lost Nearly 1 Million Medicare Members. Here's Why Investors Aren't Worried
- UnitedHealth Group boosts earnings outlook after stronger-than-expected Q2 results
- UnitedHealth Group: Ein Kauf nach dem jüngsten Gewinnbericht?
- JPMorgan Raises its Price Target on UnitedHealth Group (UNH)
- UnitedHealth Stock Jumps on Upgrade From Bank of America. UNH Is No Longer Just an Insurance Company.
- Täglicher Dividendenbericht: MDT, ACM, UNH, RICK, VRT
- Dieser Gesundheitsriese wird leise zu einem KI-Kraftwerk
- UnitedHealth Group (UNH) – Unter den 10 Qualitätsaktien, die laut Hedgefonds gekauft werden sollten
- UnitedHealth (UNH) Aktien fallen nach Ausstieg von Berkshire Hathaway, berichtet Reuters
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 3.752 Einreicher · $243.5B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 513 (+264 vs. Vorquartal) | 121 (-257 vs. Vorquartal) | 1.267 (+54 vs. Vorquartal) | 1.278 (-102 vs. Vorquartal) | +117.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $27.207.979.474 | 82.420.949 | 11,17% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $24.651.649.136 | 59.311.525 | 10,12% | Aktien |
| STATE STREET CORP | $18.966.554.763 | 45.633.267 | 7,79% | Aktien |
| Capital World Investors | $12.422.776.956 | 29.887.932 | 5,10% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10.175.966.547 | 24.483.234 | 4,18% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $7.770.611.877 | 18.774.463 | 3,19% | Aktien |
| FMR LLC | $7.185.101.298 | 17.287.254 | 2,95% | Aktien |
| NORGES BANK | $5.293.868.088 | 12.736.973 | 2,17% | Aktien |
| Capital Research Global Investors | $4.378.631.657 | 10.534.177 | 1,80% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $4.210.086.678 | 10.129.410 | 1,73% | Aktien |
| Fisher Asset Management, LLC | $3.774.863.715 | 9.082.269 | 1,55% | Aktien |
| Dodge & Cox | $3.770.702.593 | 9.072.258 | 1,55% | Aktien |
| Capital International Investors | $3.237.872.783 | 7.789.028 | 1,33% | Aktien |
| JANE STREET GROUP, LLC | $3.165.978.399 | 7.617.300 | 1,30% | Kaufoption |
| Sanders Capital, LLC | $2.451.649.249 | 5.898.634 | 1,01% | Aktien |
| EAGLE CAPITAL MANAGEMENT LLC | $2.399.442.912 | 5.773.026 | 0,99% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.119.167.278 | 5.098.687 | 0,87% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $2.075.268.358 | 7.669.420 | 0,85% | Aktien |
| MORGAN STANLEY | $2.055.731.816 | 4.946.062 | 0,84% | Aktien |
| JANE STREET GROUP, LLC | $2.055.124.098 | 4.944.600 | 0,84% | Verkaufsoption |
| DIMENSIONAL FUND ADVISORS LP | $1.717.292.161 | 4.131.778 | 0,71% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $1.526.781.892 | 3.673.416 | 0,63% | Aktien |
| AMERIPRISE FINANCIAL INC | $1.405.176.851 | 3.380.319 | 0,58% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1.251.138.985 | 3.010.223 | 0,51% | Aktien |
| Grantham, Mayo, Van Otterloo & Co. LLC | $1.174.164.878 | 2.825.022 | 0,48% | Aktien |
| BlackRock, Inc. | $1.158.005.862 | 2.786.146 | 0,48% | Aktien |
| UBS Group AG | $1.092.471.817 | 2.628.472 | 0,45% | Kaufoption |
| BANK OF AMERICA CORP /DE/ | $1.087.853.337 | 2.617.360 | 0,45% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $1.065.664.884 | 2.563.973 | 0,44% | Aktien |
| Swiss National Bank | $1.064.029.841 | 2.560.041 | 0,44% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $1.055.107.927 | 2.538.575 | 0,43% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $971.757.071 | 2.338.034 | 0,40% | Aktien |
| BARCLAYS PLC | $897.842.266 | 2.160.196 | 0,37% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $874.984.816 | 2.105.201 | 0,36% | Aktien |
| Walleye Trading LLC | $861.060.671 | 2.071.700 | 0,35% | Verkaufsoption |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $860.919.095 | 2.071.359 | 0,35% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $847.773.811 | 2.039.732 | 0,35% | Aktien |
| Walleye Trading LLC | $845.183.605 | 2.033.500 | 0,35% | Kaufoption |
| Vanguard Global Advisers, LLC | $819.257.021 | 1.971.121 | 0,34% | Aktien |
| National Pension Service | $818.929.089 | 1.970.332 | 0,34% | Aktien |
| WOLVERINE TRADING, LLC | $815.453.232 | 2.362.400 | 0,33% | Kaufoption |
| ENVESTNET ASSET MANAGEMENT INC | $811.129.699 | 1.951.573 | 0,33% | Aktien |
| California Public Employees Retirement System | $799.750.674 | 1.924.189 | 0,33% | Aktien |
| Pentwater Capital Management LP | $777.228.100 | 1.870.000 | 0,32% | Kaufoption |
| Legal & General Group Plc | $771.950.431 | 1.857.302 | 0,32% | Aktien |
| HSBC HOLDINGS PLC | $751.372.125 | 1.802.500 | 0,31% | Verkaufsoption |
| MILLENNIUM MANAGEMENT LLC | $672.345.116 | 1.617.653 | 0,28% | Aktien |
| GOLDMAN SACHS GROUP INC | $636.389.783 | 1.531.145 | 0,26% | Aktien |
| MARSHFIELD ASSOCIATES | $634.316.697 | 1.526.157 | 0,26% | Aktien |
| UBS Group AG | $621.815.730 | 1.496.080 | 0,26% | Aktien |
| RHUMBLINE ADVISERS | $607.608.189 | 1.461.895 | 0,25% | Aktien |
| Ensign Peak Advisors, Inc | $599.888.338 | 1.443.323 | 0,25% | Aktien |
| Qube Research & Technologies Ltd | $584.349.595 | 1.405.937 | 0,24% | Aktien |
| Caisse de depot et placement du Quebec | $566.755.977 | 1.363.607 | 0,23% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $566.576.841 | 1.363.176 | 0,23% | Aktien |
| Assenagon Asset Management S.A. | $542.834.808 | 1.306.053 | 0,22% | Aktien |
| 1832 Asset Management L.P. | $537.572.517 | 1.293.392 | 0,22% | Aktien |
| LPL Financial LLC | $531.650.741 | 1.279.144 | 0,22% | Aktien |
| Davis Selected Advisers | $529.839.298 | 1.274.650 | 0,22% | Aktien |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $528.071.215 | 1.270.532 | 0,22% | Aktien |
| WOLVERINE TRADING, LLC | $512.799.408 | 1.485.600 | 0,21% | Verkaufsoption |
| HSBC HOLDINGS PLC | $508.842.509 | 1.224.268 | 0,21% | Aktien |
| FIL Ltd | $462.416.638 | 1.112.568 | 0,19% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $461.418.710 | 1.110.167 | 0,19% | Aktien |
| Ninety One UK Ltd | $458.593.637 | 1.103.370 | 0,19% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $456.902.059 | 1.099.300 | 0,19% | Kaufoption |
| Nuveen Asset Management, LLC | $449.500.757 | 888.587 | 0,18% | Aktien |
| Veritas Asset Management LLP | $448.132.682 | 1.078.201 | 0,18% | Aktien |
| NAYA CAPITAL MANAGEMENT UK LTD | $436.832.118 | 1.051.012 | 0,18% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $435.590.401 | 1.047.589 | 0,18% | Aktien |
| MACKENZIE FINANCIAL CORP | $431.689.943 | 1.038.640 | 0,18% | Aktien |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $430.280.958 | 1.035.250 | 0,18% | Aktien |
| CTC LLC | $424.566.045 | 10.215 | 0,17% | Verkaufsoption |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $411.538.954 | 990.157 | 0,17% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $408.705.604 | 983.340 | 0,17% | Aktien |
| JANE STREET GROUP, LLC | $402.713.051 | 968.922 | 0,17% | Aktien |
| CITADEL ADVISORS LLC | $400.319.438 | 963.163 | 0,16% | Aktien |
| CTC LLC | $395.596.634 | 9.518 | 0,16% | Kaufoption |
| Fayez Sarofim & Co | $394.573.729 | 949.339 | 0,16% | Aktien |
| D. E. Shaw & Co., Inc. | $382.462.726 | 920.200 | 0,16% | Verkaufsoption |
| GOLDMAN SACHS GROUP INC | $375.355.453 | 903.100 | 0,15% | Verkaufsoption |
| MILLENNIUM MANAGEMENT LLC | $372.529.169 | 896.300 | 0,15% | Verkaufsoption |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $366.901.369 | 1.355.931 | 0,15% | Aktien |
| Allen Investment Management, LLC | $364.199.528 | 876.259 | 0,15% | Aktien |
| FIRST MANHATTAN CO. LLC. | $360.530.629 | 867.432 | 0,15% | Aktien |
| PRUDENTIAL FINANCIAL INC | $359.505.403 | 864.965 | 0,15% | Aktien |
| Longview Partners (Guernsey) LTD | $350.167.028 | 842.497 | 0,14% | Aktien |
| W1M Asset Management Ltd | $349.962.345 | 842.562 | 0,14% | Aktien |
| AVIVA PLC | $347.327.444 | 835.665 | 0,14% | Aktien |
| Point72 Asset Management, L.P. | $345.328.264 | 830.855 | 0,14% | Aktien |
| TD Asset Management Inc | $337.496.548 | 812.012 | 0,14% | Aktien |
| TORONTO DOMINION BANK | $337.017.326 | 810.859 | 0,14% | Aktien |
| PineStone Asset Management Inc. | $335.630.369 | 807.522 | 0,14% | Aktien |
| JENNISON ASSOCIATES LLC | $335.325.296 | 806.788 | 0,14% | Aktien |
| PeakShares LLC | $329.595.000 | 793 | 0,14% | Aktien |
| US BANCORP \DE\ | $328.365.156 | 790.042 | 0,13% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $325.830.242 | 761.481 | 0,13% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $320.418.726 | 770.923 | 0,13% | Aktien |
| Clearbridge Investments, LLC | $312.811.372 | 752.620 | 0,13% | Aktien |
| Robeco Institutional Asset Management B.V. | $311.375.867 | 749.166 | 0,13% | Aktien |
Unternehmensinsider 64 Insider · 37 Führungskräfte · 27 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Timothy John Noel | Chief Executive Officer, UHC | 23. Juni 2026 A | 17.651 | 0 | 0 | $0 |
| Stephen J Hemsley | CEO, UHG | 23. Juni 2026 A | 48.099 | 0 | 0 | $0 |
| Heather Cianfrocco | Chief Executive Officer, Optum | 18. März 2025 A | 22.438 | 0 | 0 | $0 |
| Andrew Witty | CEO, UHG | 18. März 2025 A | 112.162 | 0 | 0 | $0 |
| Brian R Thompson | CEO, UnitedHealthcare | 24. September 2024 A | 32.675 | 0 | 0 | $0 |
| David S Wichmann | Chief Executive Officer | 16. Dezember 2020 F | 967.872 | 0 | 0 | $0 |
| Steven H Nelson | EVP & CEO, UnitedHealthcare | 25. Juni 2019 A | 38.502 | 0 | 0 | $0 |
| Larry C Renfro | Vice Chmn, UHG and CEO, Optum | 26. Juni 2018 A | 153.790 | 0 | 0 | $0 |
| Gail Boudreaux | EVP & CEO, UnitedHealthcare | 23. September 2014 A | 184.732 | 0 | 0 | $0 |
| George Lawrence Mikan III | EVP UHG & CEO, Optum | 5. Juni 2011 F | 209.279 | 0 | 0 | $0 |
| Tracy L Bahl | CEO, Uniprise | 7. November 2006 A | 4.230 | 0 | 0 | $0 |
| Robert J Sheehy | CEO, UnitedHealthcare | 7. November 2006 A | 3.009 | 0 | 0 | $0 |
| MCGUIRE WILLIAM W | Chief Executive Officer | 7. November 2006 A | 644.862 | 0 | 0 | $0 |
| Channing R Wheeler | CEO, Uniprise, Inc. | 28. November 2003 J | 8.356 | 0 | 0 | $0 |
| Wayne S Deveydt | Chief Financial Officer | 23. Juni 2026 A | 19.779 | 0 | 0 | $0 |
| John F Rex | President & CFO | 24. Juni 2025 A | 203.898 | 0 | 0 | $0 |
| Patrick J Erlandson | Chief Financial Officer | 2. Mai 2006 A | 7.083 | 0 | 0 | $0 |
| Dirk C Mcmahon | President & COO, UHG | 19. März 2024 A | 70.547 | 0 | 0 | $0 |
| Christopher R Zaetta | EVP & Chief Legal Officer | 23. Juni 2026 A | 15.860 | 0 | 0 | $0 |
| Erin Mcsweeney | EVP & Chief People Officer | 23. Juni 2026 A | 15.601 | 0 | 0 | $0 |
| Thomas E Roos | Chief Accounting Officer | 23. Februar 2026 A | 31.284 | 0 | 0 | $0 |
| Rupert M Bondy | EVP & Chief Legal Officer | 19. März 2024 A | 9.607 | 0 | 0 | $0 |
| Marianne D Short | EVP & Chief Legal Officer | 25. Februar 2022 F | 138.315 | 0 | 0 | $0 |
| Patricia L Lewis | EVP and Chief HR Officer | 13. Februar 2022 F | 8.901 | 0 | 0 | $0 |
| Ellen D Wilson | Executive Vice President | 24. März 2020 A | 58.387 | 0 | 0 | $0 |
| Eric S Rangen | Sr VP & Chief Acctg Officer | 24. Juni 2015 A | 11.577 | 0 | 0 | $0 |
| Lori Sweere | EVP, Human Capital | 10. Mai 2013 S | 70.661 | 0 | 0 | $0 |
| Richard N Baer | EVP & Chief Legal Officer | 28. Dezember 2012 F | 63.880 | 0 | 0 | $0 |
| Reed Vaughn Tuckson | EVP & Chief of Medical Affairs | 5. Juni 2012 F | 116.886 | 0 | 0 | $0 |
| William A Munsell | EVP, UnitedHealth Group | 5. Juni 2012 F | 268.167 | 0 | 0 | $0 |
| Anthony Welters | EVP, UnitedHealth Group | 5. Juni 2012 F | 119.909 | 0 | 0 | $0 |
| Christopher James Walsh | EVP and General Counsel | 24. Mai 2011 A | 101.338 | 0 | 0 | $0 |
| Mitchell Eliot Zamoff | EVP and General Counsel | 24. Mai 2011 A | 113.613 | 0 | 0 | $0 |
| Thomas L Strickland | EVP & Chief Legal Officer | 5. Juni 2008 A | 147.182 | 0 | 0 | $0 |
| Richard H Anderson | EVP, Pres, Commercial Svcs Grp | 28. Mai 2007 A | 40.606 | 0 | 0 | $0 |
| Lois E Quam | EVP & Pres, Pub & Sr Mkt Grp | 28. Mai 2007 A | 13.915 | 0 | 0 | $0 |
| Forrest Gregory Burke | Acting General Counsel | 17. April 2007 A | — | 0 | 0 | $0 |
| Frederick William Mcnabb III | Direktor | 1. Juli 2026 A | 15.462 | 0 | 0 | $0 |
| Kristen Gil | Direktor | 1. Juli 2026 A | 2.617 | 0 | 0 | $0 |
| Rice Valerie Montgomery MD | Direktor | 1. Juli 2026 A | 7.876 | 0 | 0 | $0 |
| John H Noseworthy | Direktor | 1. Juli 2026 A | 7.616 | 0 | 0 | $0 |
| Charles D. Baker | Direktor | 1. Juli 2026 A | 2.396 | 0 | 1 | $-9.613 |
| Timothy Patrick Flynn | Direktor | 1. Juli 2026 A | 10.875 | 0 | 0 | $0 |
| Scott Gottlieb | Direktor | 1. Juli 2026 A | 659 | 0 | 0 | $0 |
| Paul R Garcia | Direktor | 1. Juli 2026 A | 3.906 | 0 | 0 | $0 |
| Michele J Hooper | Direktor | 1. April 2026 A | 41.792 | 0 | 0 | $0 |
| BURKE RICHARD T | Direktor | 19. Mai 2022 S | 1.215.000 | 0 | 0 | $0 |
| Gail R Wilensky | Direktor | 22. März 2022 A | 24.590 | 0 | 0 | $0 |
| Glenn M Renwick | Direktor | 1. April 2021 A | 85.130 | 0 | 0 | $0 |
| BALLARD WILLIAM C JR | Direktor | 1. April 2020 A | 62.266 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| UnitedHealth Group Incorporated ×3 Einreichungen | 15. Januar 2021 | — | Erste Einreichung | — | SEC |
| Ingenix, Inc., UnitedHealth Group Incorporated | 5. Juni 2006 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 268 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IHF · iShares Trust | 21,13% | 647.431 SH | 8. August 2026 | Täglich |
| DJD · Invesco Exchange-Traded Fund Trust | 8,15% | 99.571 SH | 8. August 2026 | Täglich |
| IYH · iShares Trust | 5,93% | 540.690 SH | 8. August 2026 | Täglich |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 5,83% | 1.751 NS | 30. April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 5,56% | 2.728.542 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 5,42% | 417.583 NS | 30. April 2026 | N-PORT |
| HRTS · Tema ETF Trust | 5,24% | 7.159 NS | 31. Mai 2026 | N-PORT |
| FLAG · Global X Funds | 5,12% | 228 NS | 30. April 2026 | N-PORT |
| SCHD · SCHWAB STRATEGIC TRUST | 5,09% | 12.713.822 NS | 31. Mai 2026 | N-PORT |
| RXL · ProShares Trust | 4,98% | 9.446 NS | 31. Mai 2026 | N-PORT |
| DOGG · First Trust Exchange-Traded Fund IV | 4,95% | 8.762 NS | 30. April 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 4,84% | 18.062 NS | 30. April 2026 | N-PORT |
| DJIA · Global X Funds | 4,63% | 21.113 NS | 30. April 2026 | N-PORT |
| DYLG · Global X Funds | 4,61% | 732 NS | 30. April 2026 | N-PORT |
| VEGN · ETF Series Solutions | 4,22% | 17.678 NS | 30. April 2026 | N-PORT |
| IXJ · iShares Trust | 4,16% | 428.283 SH | 8. August 2026 | Täglich |
| GFGF · EA Series Trust | 3,98% | 3.881 NS | 29. Mai 2026 | N-PORT |
| EQIN · Columbia ETF Trust I | 3,65% | 27.252 NS | 30. April 2026 | N-PORT |
| LGRO · ALPS ETF Trust | 3,45% | 12.238 NS | 31. Mai 2026 | N-PORT |
| JXX · Janus Detroit Street Trust | 3,34% | 3.270 NS | 30. April 2026 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 3,34% | 146.788 SH | 8. August 2026 | Täglich |
| DDM · ProShares Trust | 3,30% | 45.359 NS | 31. Mai 2026 | N-PORT |
| PRVS · Parnassus Funds II | 3,25% | 1.978 NS | 30. Juni 2026 | N-PORT |
| BKDV · BNY Mellon ETF Trust II | 3,14% | 117.081 NS | 30. April 2026 | N-PORT |
| QLTY · GMO ETF Trust | 2,85% | 337.119 NS | 31. Mai 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 2,72% | 735 NS | 31. Mai 2026 | N-PORT |
| FMCX · Northern Lights Fund Trust IV | 2,67% | 8.276 NS | 31. Mai 2026 | N-PORT |
| FMCE · Northern Lights Fund Trust IV | 2,67% | 4.741 NS | 31. Mai 2026 | N-PORT |
| CBLS · Elevation Series Trust | 2,65% | 3.800 NS | 30. April 2026 | N-PORT |
| UDOW · ProShares Trust | 2,52% | 55.671 NS | 31. Mai 2026 | N-PORT |
| TBG · EA Series Trust | 2,51% | 15.609 NS | 30. April 2026 | N-PORT |
| ESN · Northern Lights Fund Trust II | 2,47% | 18.098 NS | 31. Mai 2026 | N-PORT |
| OMAH · Tidal Trust III | 2,46% | 49.724 NS | 30. April 2026 | N-PORT |
| SNPV · DBX ETF Trust | 2,35% | 14.245 NS | 29. Mai 2026 | N-PORT |
| PALC · Pacer Funds Trust | 2,35% | 14.601 NS | 30. April 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 2,25% | 2.424 NS | 31. Mai 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 2,20% | 536.993 SH | 8. August 2026 | Täglich |
| SFYF · Tidal Trust I | 2,08% | 2.389 NS | 31. Mai 2026 | N-PORT |
| FLV · AMERICAN CENTURY ETF TRUST | 2,07% | 19.236 NS | 31. Mai 2026 | N-PORT |
| HGRO · ETF Opportunities Trust | 2,06% | 5.413 NS | 30. April 2026 | N-PORT |
| CGDV · Capital Group Dividend Value ETF | 2,02% | 1.872.479 NS | 31. Mai 2026 | N-PORT |
| GMOV · GMO ETF Trust | 2,02% | 4.839 NS | 31. Mai 2026 | N-PORT |
| GKAT · Advisors Series Trust | 1,99% | 10.970 NS | 31. März 2026 | N-PORT |
| DUSA · Davis Fundamental ETF Trust | 1,96% | 61.270 NS | 30. April 2026 | N-PORT |
| GVIP · Goldman Sachs ETF Trust | 1,84% | 27.590 NS | 31. Mai 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 1,78% | 570.801 SH | 8. August 2026 | Täglich |
| MEDI · Harbor ETF Trust | 1,77% | 1.315 NS | 30. April 2026 | N-PORT |
| KAT · Advisors Series Trust | 1,75% | 43.653 NS | 31. März 2026 | N-PORT |
| DGRO · iShares Trust | 1,69% | 1.819.359 SH | 8. August 2026 | Täglich |
| VIG · VANGUARD SPECIALIZED FUNDS | 1,65% | 5.130.541 SH | 8. August 2026 | Täglich |